![](https://images.rodpub.com/images/309/464_main.jpg)
Immunic Welcomes Jason Tardio as COO and President
Immunic Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, has welcomed seasoned biopharmaceutical executive, Jason Tardio, as Chief Operating …